Plain-spoken notes on the compounds we supply — what the literature shows, how to read a COA, and the protocols that protect your data. Cited, never hyped.
Comparisons
Methylene Blue and J-147 are both studied as mitochondria-targeting nootropic compounds, but their chemistry and mechanisms diverge sharply. A research-use comparison of an old…
Skin & matrix
A deep research guide to GHK-Cu, the copper-binding tripeptide Gly-His-Lys. Coordination chemistry, extracellular-matrix and gene-expression mechanisms, and an honest in-vitro to limited-human evidence map.…
Comparisons
The name 'TB-500' covers two unrelated research molecules: full-length thymosin β4 (43 aa) and short Tβ4-derived fragments. What each one actually is, what the…
Guides
A provider-neutral, evidence-first checklist for evaluating any European research-peptide supplier — by the documentation you can verify, not the marketing you have to trust.
In the news
The GLP-1 shortage spawned a compounding boom. As the FDA winds it down, semaglutide is left as three distinct things that share a molecule's…
Regulation
The 2026 list names dozens of peptides as prohibited at all times for athletes — BPC-157 in S0, TB-500 and thymosin-β4 in S2, MOTS-c…
Regulation
RUO is a labelling category about intended use, not a quality grade or a safety claim. It is legitimate for genuine laboratory science —…
Methods & QC
A lyophilised vial and a pre-portioned capsule are not two flavours of the same product. They are two answers to two different experimental questions…
Methods & QC
A methods comparison for laboratory sample preparation: how solubility, pH, preservatives and stock longevity dictate which diluent reconstitutes a lyophilised research peptide cleanly.
Guides
A field map for researchers: how synthetic, sequence-defined peptides are classified, made and characterised — and why the honest evidence runs from approved drugs…
Comparisons
Three peptides chase the same idea — stabilise growth-hormone-releasing hormone so it drives pulsatile GH at the pituitary. They are not three equal options.…
Comparisons
Two peptides from one scaffold took opposite paths — one to a regulatory approval, the other to the grey market. A precise, evidence-honest comparison…
Occasional, considered notes on the compounds and the literature. No noise.
Subscribe & earn 500 pointsCookies
We use strictly necessary cookies to run the store. With your consent we also use analytics (order attribution) and marketing (Omnisend) cookies. Read our Cookie Policy.
